SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000950123-10-103944
Filing Date
2010-11-10
Accepted
2010-11-10 16:43:43
Documents
2
Group Members
ADVENT HEALTHCARE AND LIFE SCIENCES III A LIMITED PARTNERSHIADVENT HEALTHCARE AND LIFE SCIENCES III LIMITED PARTNERSHIPADVENT INTERNATIONAL LLCADVENT PARTNERS HLS III LIMITED PARTNERSHIPAHLS III GP LIMITED PARTNERSHIP

Document Format Files

Seq Description Document Type Size
1 SC 13D b83409sc13d.htm SC 13D 160601
2 EX-99.1 b83409exv99w1.htm EX-99.1 7197
  Complete submission text file 0000950123-10-103944.txt   170064
Mailing Address 75 STATE STREET BOSTON MA 02109
Business Address 75 STATE STREET BOSTON MA 02109 6179519400
ADVENT INTERNATIONAL CORP/MA (Filed by) CIK: 0001034196 (see all company filings)

IRS No.: 042840139 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807
Business Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807 (908) 704-1300
Aegerion Pharmaceuticals, Inc. (Subject) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-85739 | Film No.: 101180560
SIC: 2834 Pharmaceutical Preparations